Search
Inebilizumab
go.drugbank.com/drugs/DB12530ApprovedInvestigational[L49861] In April 2025, inebilizumab was additionally approved by the FDA for immunoglobulin G4-related disease (IgG4-RD).[L52705,L14315] It is the first and only FDA-approved treatment for IgG4-RD. … [L52705] In December 2025, the FDA approved an additional indication for generalized myasthenia gravis. [L54838]
Fedratinib
go.drugbank.com/drugs/DB12500ApprovedInvestigational[A183188] Fedratinib was granted FDA approval on August 16, 2019.[L8090] … Fedratinib, also known as SAR302503 and TG101348, is a tyrosine kinase inhibitor used to treat intermediate-2 and high risk primary and secondary myelofibrosis.
Zonampanel anhydrous
go.drugbank.com/drugs/DB20448InvestigationalZonampanel anhydrous has a monoisotopic molecular weight of 331.06 Da. … Zonampanel anhydrous is a small molecule drug.
Risovalisib
go.drugbank.com/drugs/DB21474InvestigationalRisovalisib has a monoisotopic molecular weight of 598.19 Da. … Risovalisib is a small molecule drug.
Retezorogant
go.drugbank.com/drugs/DB21592ExperimentalRetezorogant has a monoisotopic molecular weight of 420.22 Da. … Retezorogant is a small molecule drug.
Ospemifene
go.drugbank.com/drugs/DB04938ApprovedFDA approved on February 26, 2013. … Ospemifene is a new selective non-hormonal estrogen receptor modulator (SERM) that is used for the treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause
Evifacotrep
go.drugbank.com/drugs/DB21510InvestigationalEvifacotrep has a monoisotopic molecular weight of 441.06 Da. … Evifacotrep is a small molecule drug. The usage of the INN stem '-cotrep' in the name indicates that Evifacotrep is a transient receptor potential canonical channel 5 (TRPC5) antagonist.
Zosurabalpin
go.drugbank.com/drugs/DB21539InvestigationalZosurabalpin has a monoisotopic molecular weight of 790.36 Da. … Zosurabalpin is a small molecule drug.
Carafiban
go.drugbank.com/drugs/DB19813ExperimentalCarafiban has a monoisotopic molecular weight of 465.2 Da. … Carafiban is a small molecule drug. The usage of the INN stem '-fiban' in the name indicates that Carafiban is a fibrinogen receptor antagonist (glycoprotein IIb/IIIa receptor antagonist).
Licostinel
go.drugbank.com/drugs/DB19864ExperimentalLicostinel has a monoisotopic molecular weight of 274.95 Da. … Licostinel is a small molecule drug. The usage of the INN stem '-stinel' in the name indicates that Licostinel is a N-methyl-D-aspartate (NMDA) receptor co-agonist.